Healthcare provider profile · identity verified

Kenneth Wayne Schmidt, MD

Family Practice · CHATHAM, IL · NPI 1225183890

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	281	114
Omeprazole	Omeprazole	238	85
Amlodipine Besylate	Amlodipine Besylate	231	102
Levothyroxine Sodium	Levothyroxine Sodium	215	85
Gabapentin	Gabapentin	202	61
Losartan Potassium	Losartan Potassium	200	73
Metoprolol Succinate	Metoprolol Succinate	167	52
Lisinopril	Lisinopril	165	65
Furosemide	Furosemide	147	54
Hydrochlorothiazide	Hydrochlorothiazide	141	52
Albuterol Sulfate Hfa	Albuterol Sulfate	131	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	127	35
Tramadol Hcl	Tramadol Hcl	116	39
Tamsulosin Hcl	Tamsulosin Hcl	106	43
Simvastatin	Simvastatin	101	43
Metformin Hcl	Metformin Hcl	100	43
Montelukast Sodium	Montelukast Sodium	94	35
Eliquis	Apixaban	92	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	29
Meloxicam	Meloxicam	86	28
Metoprolol Tartrate	Metoprolol Tartrate	82	34
Pantoprazole Sodium	Pantoprazole Sodium	81	30
Sertraline Hcl	Sertraline Hcl	80	31
Potassium Chloride	Potassium Chloride	77	33
Allopurinol	Allopurinol	76	33
Citalopram Hbr	Citalopram Hydrobromide	74	22
Jardiance	Empagliflozin	73	19
Trazodone Hcl	Trazodone Hcl	71	25
Rosuvastatin Calcium	Rosuvastatin Calcium	69	34
Carvedilol	Carvedilol	64	26
Famotidine	Famotidine	64	23
Mirtazapine	Mirtazapine	60	19
Clopidogrel	Clopidogrel Bisulfate	53	22
Doxycycline Hyclate	Doxycycline Hyclate	52	44
Alprazolam	Alprazolam	49	17
Glimepiride	Glimepiride	48	20
Pravastatin Sodium	Pravastatin Sodium	47	19
Tizanidine Hcl	Tizanidine Hcl	47	21
Fluoxetine Hcl	Fluoxetine Hcl	46	14
Ezetimibe	Ezetimibe	45	21
Venlafaxine Hcl Er	Venlafaxine Hcl	44	13
Alendronate Sodium	Alendronate Sodium	42	12
Glipizide	Glipizide	42	20
Hydroxyzine Hcl	Hydroxyzine Hcl	42	16
Zolpidem Tartrate	Zolpidem Tartrate	42	14
Celecoxib	Celecoxib	41	14
Duloxetine Hcl	Duloxetine Hcl	41	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	16
Pioglitazone Hcl	Pioglitazone Hcl	40	16
Paroxetine Hcl	Paroxetine Hcl	38	12
Finasteride	Finasteride	36	17
Methylprednisolone	Methylprednisolone	35	29
Fenofibrate	Fenofibrate Nanocrystallized	32	12
Pregabalin	Pregabalin	32	suppressed
Lorazepam	Lorazepam	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	11
Atenolol	Atenolol	29	suppressed
Doxepin Hcl	Doxepin Hcl	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	18
Metformin Hcl Er	Metformin Hcl	28	11
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	11
Lovastatin	Lovastatin	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	17
Clonidine Hcl	Clonidine Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Prednisone	Prednisone	17	suppressed
Topiramate	Topiramate	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Baclofen	Baclofen	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Linzess	Linaclotide	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Valsartan	Valsartan	15	suppressed
Azithromycin	Azithromycin	14	14
Clindamycin Hcl	Clindamycin Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Naproxen	Naproxen	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Ozempic	Semaglutide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Diazepam	Diazepam	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error